Simon Clinch
Stock Analyst at Redburn Partners
Total Price Targets
9
Stocks Covered
7
Sectors
Financial Services, Industrials
Most Recent
Apr 16, 2024
Stocks Covered by Simon Clinch
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| TRU | TransUnion | $98.00 | $78.63 | +24.6% | 2 | Apr 16, 2024 |
| COIN | Coinbase Global, Inc. | $70.00 | $149.81 | -53.3% | 2 | May 30, 2023 |
| EFX | Equifax Inc. | $230.00 | $173.73 | +32.4% | 1 | Nov 15, 2022 |
| ICE | Intercontinental Exchange, Inc. | $125.00 | $152.62 | -18.1% | 1 | Aug 19, 2022 |
| CME | CME Group Inc. | $235.00 | $268.47 | -12.5% | 1 | Jun 10, 2022 |
| UPST | Upstart Holdings, Inc. | $45.00 | $27.41 | +64.2% | 1 | May 13, 2022 |
| NDAQ | Nasdaq, Inc. | $73.33 | $94.53 | -22.4% | 1 | Sep 14, 2021 |
Recent Activity
- Apr 16, 2024— Set$98.00price target onTRU(TransUnion)
- May 30, 2023— Set$70.00price target onCOIN(Coinbase Global, Inc.)
- Nov 15, 2022— Set$230.00price target onEFX(Equifax Inc.)
- Sep 22, 2022— Set$90.00price target onTRU(TransUnion)
- Aug 19, 2022— Set$125.00price target onICE(Intercontinental Exchange, Inc.)
- Jul 6, 2022— Set$35.00price target onCOIN(Coinbase Global, Inc.)
- Jun 10, 2022— Set$235.00price target onCME(CME Group Inc.)
- May 13, 2022— Set$45.00price target onUPST(Upstart Holdings, Inc.)
- Sep 14, 2021— Set$73.33price target onNDAQ(Nasdaq, Inc.)
Frequently Asked Questions
Who is Simon Clinch?
Simon Clinch is a stock analyst at Redburn Partners covering 7 stocks primarily in Financial Services, Industrials. They have issued 9 price targets since Sep 14, 2021.
What stocks does Simon Clinch cover?
Simon Clinch currently covers 7 stocks, including TRU, COIN, EFX, ICE, CME.
What is Simon Clinch's latest price target?
Simon Clinch's most recent price target was $98.00 on TRU (TransUnion), set on Apr 16, 2024.
What is Simon Clinch's highest price target?
Simon Clinch's highest issued price target is $235.00 on CME, set on Jun 10, 2022.
More Analysts at Redburn Partners
Coverage based on publicly published price targets. Not investment advice.